Overactive Bladder (OAB) - Renal and Urology News

RSS | Login | Register

Overactive Bladder

Study: Most OAB Cases Go Untreated

Jody A. Charnow February 05, 2010

The associated cost is a potential reason for undertreatment.

Study: Most Overactive Bladder Cases Go Untreated

Jody A. Charnow January 11, 2010

Only 24.4% of patients aged 45 years and older take drugs for the condition, according to researchers.

PTNS Provides Sustained Overactive Bladder Relief

Jill Stein November 19, 2009

Study findings at 12 months showed prolonged significant improvements in objective urinary parameters.

OAB Meds Not Equal When It Comes To Adverse Effects

Rosemary Frei, MSc October 22, 2009

Solifenacin-treated patients experienced less dry mouth than those taking oxybutynin immediate release.

Nerve Stimulation An Overactive Bladder Option

Jody A. Charnow September 17, 2009

Percutaneous tibial nerve stimulation may be considered an alternative treatment for overactive bladder (OAB), researchers reported in the Journal of Urology (2009;182:1055-1061).

Patent Issued for OAB Neuromodulation System

Jody A. Charnow August 19, 2009

Uroplasty, Inc., a medical device company with headquarters in Minnetonka, Minn., has received a patent for its Urgent PC Neuromodulation System and stimulation methods for treating overactive bladder (OAB).

Novel Botox Therapy May Work for Idiopathic Refractory OAB

Jody A. Charnow August 10, 2009

Researchers have reported encouraging results from a small study examining intravesical instillation of a botulinum toxin/dimethyl sulfoxide (DMSO) solution as a treatment for refractory idiopathic overactive bladder (OAB).

First and Only Topical Gel for Overactive Bladder Cleared

Jody A. Charnow July 23, 2009

Watson Pharmaceuticals, Corona, Calif., has received approval for Gelnique (oxybutynin chloride) Gel 10%, the first and only topical gel for the treatment of overactive bladder (OAB).

$Sacral Neuromodulation Can Ease Refractory Overactive Bladder in the Elderly$

Sacral Neuromodulation Can Ease Refractory Overactive Bladder in the Elderly

Sandip P. Vasavada, MD July 20, 2009

The procedure is ideal in this population because it is minimally invasive and highly efficacious

$Diagnosing, Treating Refractory OAB$

Diagnosing, Treating Refractory OAB

Mia A. Swartz, MD, MPH, Sandip P. Vasavada, MD April 02, 2009

Idiopathic overactive bladder (OAB) is a common condition in the United States, with a prevalence of 16% for men and 16.9% for women (World J Urol. 2003;20:327-336). OAB is costly, with related expenditures for 2000 estimated